Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
about
FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expressionHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsResveratrol as a natural anti-tumor necrosis factor-α molecule: implications to dendritic cells and their crosstalk with mesenchymal stromal cellsMicrovesicles derived from human Wharton's jelly mesenchymal stem cells promote human renal cancer cell growth and aggressiveness through induction of hepatocyte growth factor.Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.Synovial fluid of patients with rheumatoid arthritis induces alpha-smooth muscle actin in human adipose tissue-derived mesenchymal stem cells through a TGF-beta1-dependent mechanism.Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivoBone marrow stromal cells produce long-term pain relief in rat models of persistent pain.Modulation of Apoptosis and Differentiation by the Treatment of Sulfasalazine in Rabbit Articular Chondrocytes.Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells--a rheumatoid arthritis mouse model.Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment.Multipotent stromal cells for arthritic joint pain therapy and beyond.Follistatin-like protein 1 and its role in inflammation and inflammatory diseases.Role of inflammatory factors and adipose tissue in pathogenesis of rheumatoid arthritis and osteoarthritis. Part I: Rheumatoid adipose tissue.Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.Cartilage regeneration by selected chondrogenic clonal mesenchymal stem cells in the collagenase-induced monkey osteoarthritis model.Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E2-dependent mechanisms.Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis.The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice.
P2860
Q24633625-B843FA56-8B7F-4E90-93C8-F47B6CEF8027Q28071916-9BEF3B63-5B10-4C1D-8B08-4D3A4F0828C6Q28540693-12B59922-8941-4CB3-AD21-3D64092E9EC0Q33568086-AF9096AC-8ACB-440A-92B3-91DA0432C613Q34038859-52A3E6A6-94B9-4940-9E02-FCC4E6AC47E0Q34086782-C4CE3C79-E909-4CF8-BB26-9C6EC3A2025EQ34674941-3E697ACD-D14C-45F0-8577-7AEAF67C6ACBQ35750606-585E692A-BE95-4639-BE53-45A899AC61CAQ36832831-9BAA0BC0-A811-4F6B-825F-2A8DE467F3F8Q37372205-2FD9DF8B-A9F0-40E8-B385-C63DDFF4D308Q37905056-362D2056-14C2-450F-A858-06E2409EA332Q38072064-A5B677B7-678E-46D1-BC02-739C90DBBF52Q38196929-D55CBFB9-8B78-4D76-A520-4D2B651A7B90Q38212545-6E87BCA3-7CC8-4231-9108-587323AACC9FQ38671127-DC3B0A7A-F039-4B1F-8AF8-6BED9DC7E957Q38840236-50BFE198-E733-4D7B-8922-D0382DE687B8Q42914079-F9C5954B-C429-44C5-8096-82E619A88004Q43948857-8339A593-B97F-4E31-A5BE-FBD3F7D2CA2CQ46436081-ED965D84-B3F5-4AD4-AFEC-2CE91EE0CAC9Q49575147-43E1AD12-D811-4D60-92DA-ADC24B8F030BQ50434732-CE66EEC5-5208-44A6-B4F4-DAB1B040E601
P2860
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
@en
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
@nl
type
label
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
@en
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
@nl
prefLabel
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
@en
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
@nl
P2860
P50
P356
P1433
P1476
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
@en
P2093
Carine Bouffi
Marc Mathieu
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEP162
P577
2009-06-26T00:00:00Z